Active Pharmaceutical Ingredients

Empowering global healthcare with precision-engineered pharmaceutical solutions

Ureda Pharmaceutical provides a wide range of high-quality Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry. Our portfolio includes Human APIs — such as Semaglutide, Tirzepatide, Liraglutide, Empagliflozin, Vildagliptin, Tenoxicam, and Tadalafil — as well as Veterinary APIs including Selamectin, Fluralaner, Oclacitinib, and Sarolaner. All APIs are manufactured in GMP-compliant facilities with FDA and international regulatory support, ensuring consistent safety, efficacy, and reliability. Our products are applied across therapeutic areas such as diabetes, cardiovascular diseases, infectious diseases, and beyond.

For API Enquiries,please mail us on: sales@uredapharm.com

API Products

Product Name

CAS NO

Grade

Chlorphenamine Maleate

113-92-8

CP/USP/EP

Lidocaine Hydrochloride

6108-05-0

CP/USP/EP

Ropivacaine Hydrochloride

132112-35-7

CP/USP/EP

Levofloxacin Hemihydrate

138199-71-0

USP/IP

Moxifloxacin Hydrochloride

186826-86-8

CP/USP/EP

Norfloxacin

70458-96-7

USP/IP

Ofloxacin

82419-36-1

USP/IP

Nifedipine

21829-25-4

CP/EP/USP/BP

Nitrendipine

39562-70-4

CP/BP/EP

Simvastatin

79902-63-9

CP/USP/EP/IP

Glipizide

29094-61-9

CP/EP/USP

Vildagliptin

274901-16-5

In-House

Esomeprazole Magnesium Trihydrate

217087-09-7

CP/USP/EP

Esomeprazole Sodium

161796-78-7

CP/USP/EP

Aceglutamide

2490-97-3

CP/USP/EP

Acetomenadione

546-88-3

CP/USP/EP

Flunarizine Dihydrochloride

30484-77-6

USP/EP

Naphazoline Hydrochloride

550-99-2

CP/USP/EP

Nicotinylmethylamide

3569-99-1

CP/USP/EP

Tadalafil

171596-29-5

CP/USP/EP

Terazosin Hydrochloride

70024-40-7

CP/EP/USP

Loxoprofen Sodium Hydrate

80382-23-6

JP/KP/In-House

Flavoxate Hydrochloride

3717-88-2

CP/EP/JP

Solifenacin Succinate

242478-38-2

USP/EP

Lanthanum Carbonate

929207-29-4

USP/EP

Eribulin Mesylate

441045-17-6

USP/EP

Remdesivir

1809249-37-3

USP/EP

Favipiravir

259793-96-9

USP/EP

Molnupiravir

2349386-89-4

USP/EP

Velpatasvir

1377049-84-7

USP/EP

Oseltamivir Phosphate

204255-11-8

USP/EP

Cimetidine

51481-61-9

USP/EP

Peramivir Trihydrate

1041434-82-5

USP/EP

Semaglutide

910463-68-2

In-House

Tirzepatide

2023788-19-2

In-House

Liraglutide

204656-20-2

In-House

Tenoxicam

59804-37-4

EP

Muoirocin

12650-69-0

USP/EP

Polymycin B Sulfate

1405-20-5

USP/EP

Lidocaine Hydrochloride

6108-05-0

USP/EP

Betamethasone

378-44-9

USP/EP/IP

Dexamethasone

50-05-2

USP/EP/IP

Dydrogesterone

152-62-5

USP/EP

Dutasteride

164656-23-9

USP/EP

Finasteride

98319-26-7

USP/EP

Prednisone

53-03-2

USP/EP/BP

Prednisolone

50‑24‑8

USP/EP/BP

Methylprednisolone

83-43-2

USP/EP/BP

Hydrocortisone

50‑23‑7

SP/EP/BP

Budesonide

51333-22-3

USP/EP

Fludrocortisone acetate

514-36-3

USP/EP

Fluticasone propionate

80474-14-2

USP/EP

Oxytocin

50-56-6

USP/EP

Solifenacin Succinate

242478-38-2

USP/EP

Flavoxate Hydrochloride

3717-88-2

EP/JP

Notes: The above products are only use for R&D, not for commercial use; Products not avaliable in countries where the patent exists.

Request For A Quote

Please fill out the form below, and we will contact you within 24 hours.

If you have any questions, feel free to contact us at sales@uredapharm.com